Efficacy and Safety of BRAF Inhibition Alone Versus Combined BRAF and MEK Inhibition in Melanoma: A Meta-Analysis of Randomized Controlled Trials
Oncotarget - United States
doi 10.18632/oncotarget.15632
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 23, 2017
Authors
Publisher
Impact Journals, LLC